Literature DB >> 28774869

Overactivation of intestinal sterol response element-binding protein 2 promotes diet-induced nonalcoholic steatohepatitis.

Pooja Malhotra1, Costica Aloman2, Aparna Ankireddy1, Hani Khadra1, Kohtaro Ooka2, Ravinder K Gill1, Seema Saksena3,1, Pradeep K Dudeja3,1, Waddah A Alrefai4,1.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is characterized by lipid accumulation in the liver that may progress to hepatic fibrosis and nonalcoholic steatohepatitis (NASH). Mechanisms underlying NAFLD and NASH are not yet fully understood. Dietary cholesterol was recently shown to be a risk factor for the development of NASH, suggesting a role for intestinal handling of cholesterol. One important regulator of cholesterol homeostasis is the sterol response element-binding protein-2 (SREBP-2) transcription factor. We tested the hypothesis that the overactivation of intestinal SREBP-2 increases the susceptibility to diet-induced NASH. A transgenic mouse model with intestine-specific overexpression of active SREBP-2 (ISR2 mice) driven by villin promoter was used. ISR2 mice and their wild-type littermates were fed a regular chow diet or a high-fat, high-cholesterol (HFHC) diet (15% fat, 1% cholesterol) for 15 wk. Results showed that HFHC feeding to ISR2 mice caused hepatic inflammation with increased levels of proinflammatory cytokines. Histological examination demonstrated extensive fibrosis after a HFHC diet associated with a perivascular as well as pericellular collagen deposits in ISR2 mice compared with wild-type littermates. The severe hepatic inflammation and advanced fibrosis in ISR2 mice was not associated with a difference in lipid accumulation in ISR2 mice compared with wild type littermates after HFHC feeding. These data indicate that overactivation of intestinal SREBP2 promotes diet-induced hepatic inflammation with features of human NASH resulting in rapid severe fibrosis and provide a novel link between regulatory processes of intestinal cholesterol and progression of fatty liver.NEW & NOTEWORTHY The current study highlights the role of overactivation of intestinal SREBP-2 transcription factor in the progression of hepatic fibrosis associated with diet-induced NASH. Mice with intestine-specific overexpression of SREBP-2 demonstrated more inflammation and severe fibrosis in the liver in response to 15 wk of being fed a high-cholesterol, high-fat diet as compared with their wild-type littermates. These data demonstrate a novel link between intestinal regulatory processes of cholesterol metabolism and the pathogenesis of fatty liver diseases.

Entities:  

Keywords:  ISR2 mice; high cholesterol; high fat; intestinal sterol response element-binding protein 2; liver fibrosis; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis

Mesh:

Substances:

Year:  2017        PMID: 28774869      PMCID: PMC5792218          DOI: 10.1152/ajpgi.00174.2017

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  30 in total

1.  PURLs: statins for patients with nonalcoholic fatty liver?

Authors:  Mari Egan; Shailendra Prasad
Journal:  J Fam Pract       Date:  2011-09       Impact factor: 0.493

Review 2.  Pathogenesis of Nonalcoholic Steatohepatitis.

Authors:  Mariana Verdelho Machado; Anna Mae Diehl
Journal:  Gastroenterology       Date:  2016-02-27       Impact factor: 22.682

3.  Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men.

Authors:  André J Tremblay; Benoît Lamarche; Valéry Lemelin; Lizbeth Hoos; Suzanne Benjannet; Nabil G Seidah; Harry R Davis; Patrick Couture
Journal:  J Lipid Res       Date:  2010-12-01       Impact factor: 5.922

4.  Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice.

Authors:  Savitha Subramanian; Leela Goodspeed; Shari Wang; Jinkyu Kim; Lixia Zeng; George N Ioannou; W Geoffrey Haigh; Matthew M Yeh; Kris V Kowdley; Kevin D O'Brien; Subramaniam Pennathur; Alan Chait
Journal:  J Lipid Res       Date:  2011-06-20       Impact factor: 5.922

5.  Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes.

Authors:  Jay D Horton; Nila A Shah; Janet A Warrington; Norma N Anderson; Sahng Wook Park; Michael S Brown; Joseph L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-25       Impact factor: 11.205

6.  Loss of Junctional Adhesion Molecule A Promotes Severe Steatohepatitis in Mice on a Diet High in Saturated Fat, Fructose, and Cholesterol.

Authors:  Khalidur Rahman; Chirayu Desai; Smita S Iyer; Natalie E Thorn; Pradeep Kumar; Yunshan Liu; Tekla Smith; Andrew S Neish; Hongliang Li; Shiyun Tan; Pengbo Wu; Xiaoxiong Liu; Yuanjie Yu; Alton B Farris; Asma Nusrat; Charles A Parkos; Frank A Anania
Journal:  Gastroenterology       Date:  2016-06-21       Impact factor: 22.682

7.  Gut microbiota-associated bile acid deconjugation accelerates hepatic steatosis in ob/ob mice.

Authors:  M-Y Park; S J Kim; E K Ko; S-H Ahn; H Seo; M-K Sung
Journal:  J Appl Microbiol       Date:  2016-07-29       Impact factor: 3.772

8.  Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease.

Authors:  Hae-Ki Min; Ashwani Kapoor; Michael Fuchs; Faridoddin Mirshahi; Huiping Zhou; James Maher; John Kellum; Russell Warnick; Melissa J Contos; Arun J Sanyal
Journal:  Cell Metab       Date:  2012-05-02       Impact factor: 27.287

9.  Microbiota prevents cholesterol loss from the body by regulating host gene expression in mice.

Authors:  Chun-Yan Zhong; Wei-Wei Sun; Yinyan Ma; Hongling Zhu; Pan Yang; Hong Wei; Ben-Hua Zeng; Qian Zhang; Yu Liu; Wen-Xia Li; Yixin Chen; Liqing Yu; Zhi-Yuan Song
Journal:  Sci Rep       Date:  2015-05-27       Impact factor: 4.379

10.  Overactivation of intestinal SREBP2 in mice increases serum cholesterol.

Authors:  Ke Ma; Pooja Malhotra; Vinay Soni; Omar Hedroug; Fadi Annaba; Amish Dudeja; Le Shen; Jerrold R Turner; Ekaterina A Khramtsova; Seema Saksena; Pradeep K Dudeja; Ravinder K Gill; Waddah A Alrefai
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240

View more
  4 in total

Review 1.  Elucidating Potential Profibrotic Mechanisms of Emerging Biomarkers for Early Prognosis of Hepatic Fibrosis.

Authors:  Mishghan Zehra; James C Curry; Sneha S Pillai; Hari Vishal Lakhani; Cory E Edwards; Komal Sodhi
Journal:  Int J Mol Sci       Date:  2020-07-03       Impact factor: 5.923

Review 2.  Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression.

Authors:  Oren Tirosh
Journal:  Oxid Med Cell Longev       Date:  2018-05-31       Impact factor: 6.543

Review 3.  Dietary cholesterol does not break your heart but kills your liver.

Authors:  Gerhard P Püschel; Janin Henkel
Journal:  Porto Biomed J       Date:  2019-06-29

4.  Srebf2 Locus Overexpression Reduces Body Weight, Total Cholesterol and Glucose Levels in Mice Fed with Two Different Diets.

Authors:  Irene Andrés-Blasco; Sebastian Blesa; Ángela Vinué; Herminia González-Navarro; José Tomás Real; Sergio Martínez-Hervás; Julián Carretero; Antonio Ferrández-Izquierdo; Felipe Javier Chaves; Ana-Bárbara García-García
Journal:  Nutrients       Date:  2020-10-14       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.